BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 3280112)

  • 1. Combination antiemetics for cisplatin chemotherapy.
    Sridhar KS; Donnelly E
    Cancer; 1988 Apr; 61(8):1508-17. PubMed ID: 3280112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-drug antiemetic combination for cisplatin chemotherapy.
    Sridhar KS; Hussein AM; Hilsenbeck S; Cairns V
    Cancer Invest; 1992; 10(3):191-9. PubMed ID: 1581829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The prevention of CDDP-induced emesis with a combination regimen including metoclopramide, dexamethasone, droperidol and diphenhydramine].
    Dozono H; Yasuda M; Yokoyama S; Takahashi S; Ochiai K; Tsuruoka M; Morimoto O; Sasaki H; Arihiro T; Terashima Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Nov; 39(11):1968-72. PubMed ID: 3429979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis. Italian Group For Antiemetic Research.
    Lancet; 1992 Jul; 340(8811):96-9. PubMed ID: 1352024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Research.
    Roila F; Tonato M; Basurto C; Picciafuoco M; Bracarda S; Donati D; Malacarne P; Monici L; Di Costanzo F; Patoia L
    J Clin Oncol; 1989 Nov; 7(11):1693-700. PubMed ID: 2681556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised, double-blind comparison of granisetron with high-dose metoclopramide, dexamethasone and diphenhydramine for cisplatin-induced emesis. An NCI Canada Clinical Trials Group Phase III Trial.
    Warr D; Wilan A; Venner P; Pater J; Kaizer L; Laberge F; Latreille J; Stewart D; O'Connell G; Osoba D
    Eur J Cancer; 1992; 29A(1):33-6. PubMed ID: 1332737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diphenhydramine for nausea and vomiting related to cancer chemotherapy with cisplatin.
    Tsavaris N; Zamanis N; Zinelis A; Tsoutsos E; Mylonakis N; Bacoyannis C; Valilis P; Sarafidou M; Kosmidis P
    J Pain Symptom Manage; 1991 Nov; 6(8):461-5. PubMed ID: 1955741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of intermittent ondansetron versus continuous infusion metoclopramide used with standard combination antiemetics in control of acute nausea induced by cisplatin chemotherapy.
    Navari RM; Province WS; Perrine GM; Kilgore JR
    Cancer; 1993 Jul; 72(2):583-6. PubMed ID: 8319191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective randomized comparison of tropisetron with and without dexamethasone against high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting.
    Malik I; Moid I; Khan Z; Hussain M
    Am J Clin Oncol; 1999 Apr; 22(2):126-30. PubMed ID: 10199444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ondansetron plus dexamethasone versus metoclopramide plus dexamethasone plus diphenhydramine in cisplatin-treated patients with ovarian cancer. Italian Group for Antiemetic Research.
    Support Care Cancer; 1994 May; 2(3):167-70. PubMed ID: 8032702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difference in persistence of efficacy of two antiemetic regimens on acute emesis during cisplatin chemotherapy. The Italian Group for Antiemetic Research.
    J Clin Oncol; 1993 Dec; 11(12):2396-404. PubMed ID: 8246029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiemetic efficacy of droperidol or metoclopramide combined with dexamethasone and diphenhydramine. Randomized open parallel study.
    Aapro MS; Froidevaux P; Roth A; Alberto P
    Oncology; 1991; 48(2):116-20. PubMed ID: 1997933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study of metoclopramide, dexamethasone, diphenhydramine and lorazepam in prevention of nausea and vomiting in cisplatin-treated male patients.
    Roila F; Basurto C; Bracarda S; Picciafuoco M; Ballatori E; Del Favero A; Tonato M
    Oncology; 1990; 47(5):415-7. PubMed ID: 2216296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin.
    Kris MG; Gralla RJ; Tyson LB; Clark RA; Cirrincione C; Groshen S
    J Clin Oncol; 1989 Jan; 7(1):108-14. PubMed ID: 2642536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiemetic efficacy of high-dose corticosteroids and droperidol in cisplatin-induced emesis: a controlled trial with droperidol and metoclopramide.
    Donovitz GS; O'Quinn AG; Smith ML
    Gynecol Oncol; 1984 Jul; 18(3):320-5. PubMed ID: 6540222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ondansetron plus dexamethasone compared to the 'standard' metoclopramide combination.
    Roila F
    Oncology; 1993; 50(3):163-7. PubMed ID: 8459986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy and side-effects of ondansetron and metoclopramide-diphenhydramine administered to control nausea and vomiting in children treated with antineoplastic chemotherapy: a prospective randomized study.
    Köseoglu V; Kürekçi AE; Sarici U; Atay AA; Ozcan O
    Eur J Pediatr; 1998 Oct; 157(10):806-10. PubMed ID: 9809818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the relationship between nausea and vomiting in patients undergoing chemotherapy. Italian Group for Antiemetic Research.
    Support Care Cancer; 1994 May; 2(3):171-6. PubMed ID: 8032703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the efficacy of tropisetron versus a metoclopramide cocktail based on the intensity of cisplatin-induced emesis.
    Chang TC; Hsieh F; Lai CH; Tseng CJ; Cheng HH; Li CL; Michael BJ; Soong YK
    Cancer Chemother Pharmacol; 1996; 37(3):279-85. PubMed ID: 8529290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.